期刊文献+

甲胎蛋白、甲胎蛋白异质体比例和异常凝血酶原联合应用在肝癌诊断中的临床意义

Clinical significance of combined application of alpha-fetoprotein,alpha-fetoprotein-L3%and des-gamma-carboxy-prothrombin in the diagnosis of hepatocellular carcinoma
下载PDF
导出
摘要 [目的]探讨甲胎蛋白(AFP)、甲胎蛋白异质体比例(AFP-L3%)及异常凝血酶原(DCP)联合应用在肝癌诊断中的价值.[方法]采用全自动化学发光免疫分析仪对126例肝癌患者和307例普通肝病患者(肝硬化158例,慢性乙型肝炎149例)血清中的AFP、AFP-L3%和DCP含量进行检测并进行分析比较.[结果]AFP、AFP-L3%和DCP水平在慢性乙型肝炎组、肝硬化组和肝癌组中逐渐升高,慢性乙型肝炎组和肝硬化组与肝癌组间差异均具有统计学意义(P<0.01);在AFP<7μg/L、7μg/L≤AFP<200μg/L和AFP≥200μg/L 3组中,肝癌患者AFP-L3%和DCP水平逐渐升高,两两组间比较差异具有统计学意义(P<0.01);肝硬化组和慢性乙型肝炎组DCP和AFP-L3%间差异均无统计学意义(P>0.05).DCP在肝癌诊断中的敏感性优于AFP和AFP-L3%,AFP-L3%在肝癌诊断中的特异性优于AFP和DCP;3项联合诊断的敏感性优于单一的血清学指标诊断.[结论]AFP-L3%、DCP和AFP在应用于肝癌诊断中时具有互补作用,联合检测可提高肝癌的诊断率. OBJECTIVE To explore the value of alpha-fetoprotein(AFP),alpha-fetoprotein-L3%(AFP-L3%)and des-gamma-carboxy-prothrombin(DCP)in the diagnosis of hepatocellular carcinoma.METHODS The serum levels of AFP,AFP-L3%and DCP in 126 patients with hepatocellular carcinoma and 307 patients with common liver disease(158 cases of liver cirrhosis and 149 cases of chronic hepatitis B)were detected and compared by automatic chemiluminescence immunoassay.RESULTS The serum levels of AFP,AFP-L3%and DCP increased gradually in the chronic hepatitis B group,the liver cirrhosis group and the hepatocellular carcinoma group,and the differences between the chronic hepatitis B group,liver cirrhosis group and hepatocellular carcinoma group were statistically significant(P<0.01).The serum levels of AFP-L3%and DCP in hepatocellular carcinoma patients increased gradually in the groups of AFP<7μg/L,7μg/L≤AFP<200μg/L and AFP≥200μg/L,and the difference between the two groups was statistically significant(P<0.01).There was no significant difference in the serum levels of DCP and AFP-L3%between the liver cirrhosis group and the chronic hepatitis B group(P>0.05).The sensitivity of DCP in the diagnosis of hepatocellular carcinoma was superior to that of AFP and AFP-L3%.The specificity of AFP-L3%in the diagnosis of hepatocellular carcinoma was superior to that of AFP and DCP.The sensitivity of the three combined diagnosis was better than that of the single serological indicator diagnosis.CONCLUSION AFP-L3%,DCP and AFP have complementary effects in the diagnosis of hepatocellular carcinoma.Combined detection can improve the diagnosis rate of hepatocellular carcinoma.
作者 金春花 JIN Chunhua(Department of Laboratory,Affiliated Hospital of Yanbian University,Yanji 133000,Jilin,China)
出处 《延边大学医学学报》 CAS 2021年第4期294-297,共4页 Journal of Medical Science Yanbian University
关键词 肝癌 甲胎蛋白异质体比例 异常凝血酶原 肿瘤标志物 诊断 hepatoma alpha-fetoprotein-L3% des-gamma-carboxy-prothrombin tumor marker diagnosis
  • 相关文献

参考文献10

二级参考文献87

  • 1Jong Young Choi,Seung Won Jung,Hee Yeon Kim,Myungshin Kim,Yonggoo Kim,Dong Goo Kim,Eun-Jee Oh.Diagnostic value of AFP-L3 and PIVKA-Ⅱin hepatocellular carcinoma according to total-AFP[J].World Journal of Gastroenterology,2013,19(3):339-346. 被引量:63
  • 2Chaur-Shine Wang,Chin-Lin Lin,Hsi-Chang Lee,Kuan-Yang Chen,Ming-Feng Chiang,Hung-Sheng Chen,Tsung-Jung Lin.Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(39):6115-6119. 被引量:19
  • 3Lai CL,Shouval D,Lok AS,陈楠(摘译),张占卿(审校).恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究[J].世界感染杂志,2006,6(4):396-396. 被引量:201
  • 4[1]Bosch FX,Ribes J,Diaz M,Cleries R.Primary liver cancer:worldwide incidence and trends.Gastroenterology 2004; 127:S5-16
  • 5[2]Bosch FX,Ribes J,Borras J.Epidemiology of primary liver cancer.Semin Liver Dis 1999; 19:271-285
  • 6[3]Zaman SN,Melia WM,Johnson RD,Portmann BC,Johnson PJ,Williams R.Risk factors in development of hepatocellular carcinoma in cirrhosis:prospective study of 613 patients.Lancet 1985; 1:1357-1360
  • 7[4]Benvegnu L,Gios M,Boccato S,Alberti A.Natural history of compensated viral cirrhosis:a prospective study on the incidence and hierarchy of major complications.Gut 2004; 53:744-749
  • 8[5]Liaw YF,Tai DI,Chu CM,Lin DY,Sheen IS,Chen TJ,Pao CC.Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis.A prospective study.Gastroenterology 1986; 90:263-267
  • 9[6]Zhang BH,Yang BH,Tang ZY.Randomized controlled trial of screening for hepatocellular carcinoma.J Cancer Res Clin Oncol 2004; 130:417-421
  • 10[7]E1-Serag HB,Mason AC,Key C.Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996in the United States.Hepatology 2001; 33:62-65

共引文献15174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部